159 related articles for article (PubMed ID: 24323182)
1. Surveillance strategy for rectal neuroendocrine tumors according to recurrence risk stratification.
Kim DH; Lee JH; Cha YJ; Park SJ; Cheon JH; Kim TI; Kim H; Kim WH; Hong SP
Dig Dis Sci; 2014 Apr; 59(4):850-6. PubMed ID: 24323182
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Clinical Outcomes of Rectal Neuroendocrine Tumors According to the Pathologic Status After Initial Endoscopic Resection: A KASID Multicenter Study.
Moon CM; Huh KC; Jung SA; Park DI; Kim WH; Jung HM; Koh SJ; Kim JO; Jung Y; Kim KO; Kim JW; Yang DH; Shin JE; Shin SJ; Kim ES; Joo YE
Am J Gastroenterol; 2016 Sep; 111(9):1276-85. PubMed ID: 27377520
[TBL] [Abstract][Full Text] [Related]
3. Recurrence pattern and surveillance strategy for rectal neuroendocrine tumors after endoscopic resection.
Chung HG; Goh MJ; Kim ER; Hong SN; Kim TJ; Chang DK; Kim YH
J Gastroenterol Hepatol; 2021 Apr; 36(4):968-973. PubMed ID: 32864790
[TBL] [Abstract][Full Text] [Related]
4. Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion.
Sekiguchi M; Sekine S; Sakamoto T; Otake Y; Nakajima T; Matsuda T; Taniguchi H; Kushima R; Ohe Y; Saito Y
J Gastroenterol; 2015 Dec; 50(12):1184-9. PubMed ID: 25936647
[TBL] [Abstract][Full Text] [Related]
5. Surgical management and outcome of rectal carcinoids in a university hospital.
Wei R; Lo OS; Law WL
World J Surg Oncol; 2015 Feb; 13():31. PubMed ID: 25889934
[TBL] [Abstract][Full Text] [Related]
6. Lymphovascular invasion as a prognostic value in small rectal neuroendocrine tumor treated by local excision: A systematic review and meta-analysis.
Kang HS; Kwon MJ; Kim TH; Han J; Ju YS
Pathol Res Pract; 2019 Nov; 215(11):152642. PubMed ID: 31585816
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor.
Kim J; Kim JH; Lee JY; Chun J; Im JP; Kim JS
BMC Gastroenterol; 2018 Jun; 18(1):77. PubMed ID: 29866049
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of small rectal carcinoid tumors in the absence of metastatic disease.
Murray SE; Sippel RS; Lloyd R; Chen H
Ann Surg Oncol; 2012 Oct; 19(11):3486-90. PubMed ID: 22707111
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors for Locoregional Recurrence in Neuroendocrine Tumors of the Rectum.
Tsang ES; McConnell YJ; Schaeffer DF; Yin Y; Speers CH; Kennecke HF
Dis Colon Rectum; 2018 Feb; 61(2):187-192. PubMed ID: 29337773
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes of Patients with Small Rectal Neuroendocrine Tumors Treated Using Endoscopic Submucosal Resection with a Ligation Device.
Takita M; Sakai E; Nakao T; Kimoto Y; Ishii R; Konishi T; Ueno S; Kanda K; Negishi R; Muramoto T; Hashimoto H; Morikawa T; Matsuhashi N; Ohata K
Digestion; 2019; 99(1):72-78. PubMed ID: 30554202
[TBL] [Abstract][Full Text] [Related]
11. Features of Late Recurrence Following Transanal Local Excision for Early Rectal Cancer.
Oh BY; Yun HR; Kim SH; Yun SH; Kim HC; Lee WY; Chun HK; Cho YB
Dis Colon Rectum; 2015 Nov; 58(11):1041-7. PubMed ID: 26445176
[TBL] [Abstract][Full Text] [Related]
12. Recurrence and Survival of Neuroendocrine Neoplasms of the Rectum: Single-Center Experience.
Storino A; Wong D; Ore AS; Gaytan-Fuentes IA; Fabrizio A; Cataldo T; Messaris E
J Gastrointest Surg; 2021 Sep; 25(9):2398-2400. PubMed ID: 33269457
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Lymph Node Metastasis and Oncologic Outcomes in Small Rectal Neuroendocrine Tumors with Lymphovascular Invasion.
Nam SJ; Kim BC; Chang HJ; Jeon HH; Kim J; Kim SY
Gut Liver; 2022 Mar; 16(2):228-235. PubMed ID: 34552040
[TBL] [Abstract][Full Text] [Related]
14. Predictors of rectal adenoma recurrence following transanal endoscopic surgery: a retrospective cohort study.
Chan T; Karimuddin AA; Raval MJ; Phang PT; Tang V; Brown CJ
Surg Endosc; 2020 Aug; 34(8):3398-3407. PubMed ID: 31512037
[TBL] [Abstract][Full Text] [Related]
15. The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.
Sugimoto S; Hotta K; Shimoda T; Imai K; Yamaguchi Y; Nakajima T; Oishi T; Mori K; Takizawa K; Kakushima N; Tanaka M; Kawata N; Matsubayashi H; Ono H
Surg Endosc; 2016 Oct; 30(10):4239-48. PubMed ID: 26718357
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of rectal neuroendocrine tumors ≤ 10 mm following endoscopic resection.
Kim GU; Kim KJ; Hong SM; Yu ES; Yang DH; Jung KW; Ye BD; Byeon JS; Myung SJ; Yang SK; Kim JH
Endoscopy; 2013 Dec; 45(12):1018-23. PubMed ID: 24288222
[TBL] [Abstract][Full Text] [Related]
17. Criteria for decision making after endoscopic resection of well-differentiated rectal carcinoids with regard to potential lymphatic spread.
Park CH; Cheon JH; Kim JO; Shin JE; Jang BI; Shin SJ; Jeen YT; Lee SH; Ji JS; Han DS; Jung SA; Park DI; Baek IH; Kim SH; Chang DK
Endoscopy; 2011 Sep; 43(9):790-5. PubMed ID: 21735371
[TBL] [Abstract][Full Text] [Related]
18. Carcinoid of the rectum risk stratification (CaRRs): a strategy for preoperative outcome assessment.
Fahy BN; Tang LH; Klimstra D; Wong WD; Guillem JG; Paty PB; Temple LK; Shia J; Weiser MR
Ann Surg Oncol; 2007 May; 14(5):1735-43. PubMed ID: 17294074
[TBL] [Abstract][Full Text] [Related]
19. Long-term prognosis of an endoscopically treated rectal neuroendocrine tumor: 10-year experience in a single institution.
Sung HY; Kim SW; Kang WK; Kim SY; Jung CK; Cho YK; Park JM; Lee IS; Choi MG; Chung IS
Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):978-83. PubMed ID: 22647741
[TBL] [Abstract][Full Text] [Related]
20. Rectal neuroendocrine tumor developing lateral lymph node metastasis after curative resection: a case report.
Tokumaru Y; Matsuhashi N; Takahashi T; Imai H; Tanaka Y; Okumura N; Yamaguchi K; Yoshida K
World J Surg Oncol; 2020 Apr; 18(1):74. PubMed ID: 32284069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
